|
Website:
http://www.incyte.com
Phone: +1 302 498-6700 |
Address:
Route 141 & Henry Clay Road
Wilmington, DELAWARE 19880 |
Company Description
Incyte Corp.. The Group's principal activities are to discover and develop drugs for the treatment of serious unmet medical needs. The Group is engaged in the development of proprietary small molecule drugs for the treatment of human immunodeficiency virus (HIV), diabetes, oncology and inflammation. The Group operates in the United States , Canada, Germany, Sweden, and the United Kingdom. Discovers and develops drugs for the treatment of serious unmet medical needs
Key People
| Chairman | Dr. Richard U. DeSchutter |
| President & Chief Executive | Dr. Paul A. Friedman |
| Executive Vice President & Chief Financial Officer | David C. Hastings |
| Vice President Finance & Treasurer | Laurent Chardonnet |
| Executive Vice President, Secretary & General Counsel | Patricia A. Schreck |
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
I
Incyte Pharmaceuticals
Incyte's platform includes database products, genomic data management software tools, microarrays, and related reagents and services which Incyte provides to the pharmaceutical and biotechnology industries to assist their drug discovery and deve...
www.incyte.com
Incyte's platform includes database products, genomic data management software tools, microarrays, and related reagents and services which Incyte provides to the pharmaceutical and biotechnology industries to assist their drug discovery and deve...
www.incyte.com
Breaking News
Reuters - Nov. 25, 2009, 2:34 PM
Forbes.com - Nov. 25, 2009, 1:40 PM
CNBC - Nov. 25, 2009, 1:32 PM
Forbes.com - Nov. 25, 2009, 12:16 PM
Forbes.com - Nov. 25, 2009, 9:28 AM
More Incyte News
